FIELD: medicine.
SUBSTANCE: method for morphological diagnosis of preeclampsia severity is proposed. The level of the optical density of intermediate placenta villas syncytiotrophoblast cytoplasm is estimated by immunohistochemistry with primary antibodies to DAI-1. At optical density values less than 0.15 cu., severe preeclampsia is diagnosed, at values above 0.15 cu., moderate preeclampsia and hypertension of pregnant women is diagnosed.
EFFECT: invention provides effective diagnosis of preeclampsia severity based on evaluation of DNA-recognizing DAI-1 receptors expression in placental tissue.
3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MORPHOLOGICAL DIAGNOSTICS OF PRE-ECLAMPSIA | 2012 |
|
RU2487657C1 |
| METHOD OF MORPHOLOGICAL DIAGNOSIS OF THE SEVERITY OF PREECLAMPSIA | 2017 |
|
RU2682251C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PRIMARY PLACENTAL INSUFFICIENCY | 2013 |
|
RU2535011C2 |
| "VIFERON" APPLICATION FOR PREGNANT WOMEN WITH HPV INFECTION TO PREVENT PLACENTA INFECTION AND PLACENTAL INSUFFICIENCY | 2015 |
|
RU2620547C1 |
| METHOD OF MORPHOLOGICAL DIAGNOSTICS OF SEVERITY DEGREE OF GESTOSIS | 2009 |
|
RU2407008C1 |
| METHOD OF PREDICTING THE RECURRENCE OF EARLY SEVERE PREECLAMPSIA BASED ON THE RESULTS OF A STUDY OF THE LEVEL OF PLACENTAL MICROVESICLES IN BLOOD PLASMA IN PATIENTS WITH SEVERE PREECLAMPSIA IN A PERSONAL HISTORY | 2022 |
|
RU2798715C1 |
| DIAGNOSTIC TECHNIQUE FOR PREMATURE DETACHMENT OF NORMALLY LOCATED PLACENTA | 2015 |
|
RU2601625C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA | 2023 |
|
RU2817206C1 |
| METHOD FOR EVALUATING THE EFFECT OF CYTOMEGALOVIRUS INFECTION ON THE ACTIVITY OF NAD-DEPENDENT ISOCITRATE DEHYDROGENASE IN VILLOUS SYNCYTIOTROPHOBLAST IN THIRD TRIMESTER OF PREGNANCY | 2015 |
|
RU2597846C1 |
| METHOD FOR ASSESSMENT OF EFFICIENCY OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN PATIENTS WITH HABITUAL MISCARRIAGE AND CIRCULATION OF ANTIPHOSPHOLIPID ANTIBODIES | 2021 |
|
RU2786456C1 |
